Biopharmaceutical, Workforce

The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is pleased to announce approximately $15.8M in planned project activities through the Institute’s Project Call 5.2 for 14 new projects in technology and workforce development that will help to address key opportunities for innovation in the biopharmaceutical industry...

Biomanufacturing, Biopharmaceutical, Collaboration, COVID-19, Innovation, Workforce

Today, the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) announced 32 coronavirus response projects to multiple organizations across the United States funded through the American Rescue Plan (ARP).

NIIMBL identified projects that will help the nation prevent, prepare for, and respond to coronavirus public health...

Biopharmaceutical, Workforce

This summer, a group of talented students received a jump start on a career in the biopharmaceutical industry during the NIIMBL eXperience.

Building on the success of previous years, NIIMBL held its third eXperience from June 14 – 25, 2021. This program gives African American/Black, Latinx and Native American college freshmen and sophomores an...

Biopharmaceutical, Workforce

The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is pleased to announce funding for 10 new projects in technology, workforce development, and their Global Health Fund initiative, resulting from the Institute’s Project Call 4.1, and with a total value of approximately $4.6M.

“Since our inception five years ago, we...

Biopharmaceutical, Workforce

The National Institute for Manufacturing Biopharmaceuticals (NIIMBL) announced 17 students selected for their 2021 NIIMBL eXperience Program. The NIIMBL eXperience is offered to African American/Black, Latinx, and Native American college freshman and sophomores students from Historically Black Colleges and Universities (HBCUs) and NIIMBL member...